- Here’s the Long-Awaited Data on Moderna’s Vaccine Trial. So Far, So Good. (Barron’s)
- Value investing has been “broke” since 2007. BofA lists 7 reasons why it may finally be poised for a comeback (Business Insider)
- JPMorgan’s Earnings Were Surprisingly Strong. It’s a Positive Sign for Other Banks. (Barron’s)
- 12 Stocks That Could Take Off—If You’re Willing to Bet Everyone Else Is Wrong (Barron’s)
- JPMorgan, Citigroup and Wells Fargo opted to stow away a combined $28 billion (Wall Street Journal)
- U.S. consumer prices climbed sharply in June (Wall Street Journal)
- As Europe’s Economies Reopen, Consumers Go on a Spending Spree (New York Times)
- Oxford Vaccine Emerges as Front-Runner (Bloomberg)
- Goldman Sachs sees the Chinese yuan strengthening to 6.70 against the dollar in the next 12 months (CNBC)
- Investing legend Bill Gross says investors should favor value over growth during the pandemic, and tipped these 4 stocks to flourish (Business Insider)
- “Long Tech Stocks” Is The Most Crowded Trade Ever (Zero Hedge)
- Banks Are Dirt Cheap: 5 Analyst Top Picks for the Rest of 2020 (24/7 Wall Street)